BEVERLY,
Mass., May 22, 2024 /PRNewswire/ -- Cambridge
Biotherapies™, a leading mental health treatment provider in
Massachusetts, proudly announces
the launch of Ketamine Infusions for Pain and Headache Management,
now available at all locations.
This new service underscores the organization's commitment to
providing revolutionary treatments that can significantly improve
the quality of life for patients suffering from chronic pain and
migraine headaches.
Innovative Pain Management Solution
Cambridge Biotherapies' Ketamine Infusions for Pain Management
positions the facility as a leader in innovative pain management
solutions, offering patients access to a treatment modality with
proven effectiveness in alleviating chronic pain and migraine
headaches. As one of the fastest growing psychiatrist-led
facilities offering ketamine infusion treatments in Boston and the surrounding areas, Cambridge
Biotherapies provides a unique, holistic experience in a homey and
comfortable setting.
Addressing the Growing Mental Health Crisis in Massachusetts
Massachusetts is facing a
growing mental health crisis, with increasing numbers of residents
seeking effective treatment for mental health and chronic pain
conditions. By expanding services across all locations in
Amherst, Beverly, and Cambridge, Cambridge Biotherapies is committed
to meeting the rising demand for comprehensive mental health care.
The addition of Ketamine Infusions for Pain and Headache Management
is a direct response to the need for innovative, effective
treatment options in the region.
- Alternative to Opioids: Ketamine for pain is an emerging
treatment option, providing a direct alternative to opioids amidst
the opioid crisis, with controlled pain management.
- Access to Effective Treatment: Patients gain access to a
new, effective treatment option that may provide relief where other
methods have failed.
- Commitment to Cutting-Edge Treatment: This launch
demonstrates Cambridge Biotherapies' dedication to continually
providing advanced treatment options that can improve patients'
quality of life.
According to recent studies, Ketamine Infusions have shown
significant effectiveness in reducing pain for patients with
various chronic pain conditions. A study published in the Journal
of Pain Research found that 75% of patients with Complex Regional
Pain Syndrome (CRPS) experienced significant pain relief after
receiving Ketamine Infusions. Additionally, research indicates
reduced overall opioid use compared to control groups, highlighting
ketamine's potential as a safer pain management option.
"At Cambridge Biotherapies, we are dedicated to transforming
mental health and pain management by offering the most innovative
and effective treatments available," said Daniel Brenner, M.D., Founder and Medical
Director of Cambridge Biotherapies. "Our new Ketamine Infusions for
Pain Management provide hope and relief for patients who have
struggled with chronic pain, giving them a new lease on life."
With over 50 million Americans seeking mental health treatment
annually, the addition of Ketamine Infusions for Pain Management
provides an essential service that addresses both mental health and
chronic pain, offering holistic care that integrates mental and
physical health support.
For more information and to schedule a no-charge consultation,
visit CambridgeBiotherapies.com or call (888) 646-0566.
About Cambridge Biotherapies
Cambridge Biotherapies™
is a leading private mental health treatment center committed to
redefining mental health care. Led by Harvard-trained Psychiatrist and Chief Medical
Officer, Daniel Brenner, M.D., their
multi-specialty team specializes in groundbreaking treatments such
as Accelerated Transcranial Magnetic Stimulation (TMS), Ketamine
Infusion Therapy, and Psychedelic Therapy, in addition to
traditional Medication Management and Psychotherapy. With three
locations and recognition as one of Massachusetts's fastest-growing mental health
providers, Cambridge Biotherapies is dedicated to providing
leading-edge treatments and transforming lives.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cambridge-biotherapies-expands-innovative-services-with-ketamine-infusions-for-opioid-free-pain-management-302153105.html
SOURCE Cambridge Biotherapies